Cytosorbents Corporation (CTSO)
Largest Insider Buys in Sector
CTSO Stock Price History Chart
CTSO Stock Performance
About Cytosorbents Corporation
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs …
Insider Activity of Cytosorbents Corporation
Over the last 12 months, insiders at Cytosorbents Corporation have bought $305,002 and sold $0 worth of Cytosorbents Corporation stock.
On average, over the past 5 years, insiders at Cytosorbents Corporation have bought $170,876 and sold $114,827 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Chan Phillip P. (Chief Executive Officer) — $100,000. BATOR MICHAEL G. (director) — $50,000. BLOCH KATHLEEN P. (Chief Financial Officer) — $50,000.
The last purchase of 75,188 shares for transaction amount of $100,000 was made by Chan Phillip P. (Chief Executive Officer) on 2023‑12‑13.
List of Insider Buy and Sell Transactions, Cytosorbents Corporation
| 2023-12-13 | Chief Executive Officer | 75,188 0.129% | $1.33 | $100,000 | -42.61% | |||
| 2023-12-13 | President & COO | 18,797 0.0322% | $1.33 | $25,000 | -42.61% | |||
| 2023-12-13 | Chief Financial Officer | 37,594 0.0645% | $1.33 | $50,000 | -42.61% | |||
| 2023-12-13 | Chief Medical Officer | 22,557 0.0387% | $1.33 | $30,001 | -42.61% | |||
| 2023-12-13 | director | 37,594 0.0645% | $1.33 | $50,000 | -42.61% | |||
| 2023-12-13 | director | 22,557 0.0387% | $1.33 | $30,001 | -42.61% | |||
| 2023-12-13 | director | 7,519 0.0129% | $1.33 | $10,000 | -42.61% | |||
| 2023-12-13 | director | 7,519 0.0129% | $1.33 | $10,000 | -42.61% | |||
| 2023-08-07 | director | 2,000 0.0046% | $3.17 | $6,350 | -67.31% | |||
| 2023-08-04 | director | 1,000 0.0023% | $3.23 | $3,230 | -68.13% | |||
| 2023-05-25 | Interim CFO | 3,300 0.0076% | $2.85 | $9,389 | -51.31% | |||
| 2023-05-10 | Interim CFO | 10,000 0.0212% | $3.11 | $31,058 | -54.17% | |||
| 2022-12-08 | Chief Executive Officer | 5,859 0.0136% | $1.26 | $7,382 | +121.60% | |||
| 2022-12-07 | Chief Executive Officer | 9,850 0.0221% | $1.26 | $12,411 | +114.73% | |||
| 2022-12-06 | Chief Executive Officer | 14,291 0.0324% | $1.26 | $18,064 | +116.41% | |||
| 2022-08-25 | 1,000 0.0021% | $1.91 | $1,910 | +33.82% | ||||
| 2022-06-21 | President and COO | 2,000 0.0047% | $1.80 | $3,600 | +22.73% | |||
| 2022-06-16 | Chief Executive Officer | 2,221 0.005% | $1.85 | $4,109 | +14.44% | |||
| 2022-06-16 | See Remarks | 3,000 0.0074% | $2.00 | $6,000 | +14.44% | |||
| 2022-06-09 | Chief Executive Officer | 16,000 0.0366% | $2.17 | $34,784 | -2.29% |
Insider Historical Profitability
| Chan Phillip P. | Chief Executive Officer | 1068704 1.9635% | $0.91 | 15 | 4 | +34.83% |
| Capponi Vincent | President & COO | 584134 1.0732% | $0.91 | 5 | 16 | +26.1% |
| BLOCH KATHLEEN P. | Chief Financial Officer | 467941 0.8597% | $0.91 | 15 | 11 | +6.75% |
| Deliargyris Efthymios | Chief Medical Officer | 348433 0.6402% | $0.91 | 1 | 0 | |
| BATOR MICHAEL G. | director | 125394 0.2304% | $0.91 | 6 | 0 | +22.88% |
Institutional Investor Ownership
| Avenir Corp | $3.01M | 5.84 | 3.17M | +3.98% | +$115,229.29 | 0.26 | |
| Granahan Investment Management | $2.89M | 5.61 | 3.04M | -15.85% | -$544,644.43 | 0.1 | |
| Skylands Capital LLC | $2.73M | 5.3 | 2.88M | -11.64% | -$359,727.90 | 0.38 | |
| The Vanguard Group | $1.85M | 3.59 | 1.95M | 0% | +$0 | <0.0001 | |
| Neuberger Berman | $1.81M | 3.52 | 1.91M | +6.15% | +$104,971.70 | <0.01 |